Delivery Order SPE2DR25D3012-SPE2DR26F4F3A
- Not listed
- The Defense Logistics Agency awarded a $4,457.88 delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of August 25, 2025. This firm fixed-price contract, awarded on August 4, 2025, represents a non-set-aside competitive procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,991.25 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials. This competitive award, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. Performance will occur at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,078.95 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, a specialty pharmaceutical product used in pain management and joint care applications. The award, issued on December 30, 2025, with completion targeted for January 22, 2026, utilized firm fixed price contracting without any set-aside designation, indicating the contract was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively through the federal procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,438.64 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion date of November 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contracting portfolio. The delivery location is specified as the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency has awarded a delivery order valued at $4,457.88 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion date of November 26, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is classified as a delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,112.58 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with an ultimate completion date of January 30, 2026. This non-set-aside, firm fixed-price contract was competitively awarded and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The work will be performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $11,144.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract was competitively awarded on August 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Zilretta is an intra-articular injection used for pain management in osteoarthritis, representing the type of...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials. The contract, valued at $1,402.28, has an ultimate completion date of October 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support various government agencies and healthcare programs, including military treatment facilities and veterans' hospitals. The contract is not set...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4F3ADelivery Order
The Defense Logistics Agency awarded a $5,933.76 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 20, 2026, for the supply of Zilretta 32 mg vials with a completion date of February 10, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. AmerisourceBergen holds a significant position as a primary pharmaceutical vendor for federal medical procurement, particularly serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 1/19/26 |